Correlation Between Design Therapeutics and Alx Oncology
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Alx Oncology Holdings, you can compare the effects of market volatilities on Design Therapeutics and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Alx Oncology.
Diversification Opportunities for Design Therapeutics and Alx Oncology
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Design and Alx is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Alx Oncology go up and down completely randomly.
Pair Corralation between Design Therapeutics and Alx Oncology
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.88 times more return on investment than Alx Oncology. However, Design Therapeutics is 1.13 times less risky than Alx Oncology. It trades about 0.02 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.03 per unit of risk. If you would invest 903.00 in Design Therapeutics on September 3, 2024 and sell it today you would lose (303.00) from holding Design Therapeutics or give up 33.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. Alx Oncology Holdings
Performance |
| Timeline |
| Design Therapeutics |
| Alx Oncology Holdings |
Design Therapeutics and Alx Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Alx Oncology
The main advantage of trading using opposite Design Therapeutics and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.| Design Therapeutics vs. DiaMedica Therapeutics | Design Therapeutics vs. Lyra Therapeutics | Design Therapeutics vs. Centessa Pharmaceuticals PLC |
| Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |